Copyright Reports & Markets. All rights reserved.

Global Coronary Drug-Eluting Stent Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Coronary Drug-Eluting Stent Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Polymer Stent
    • 1.3.3 Polymer-Free Stent
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Coronary Drug-Eluting Stent Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Coronary Drug-Eluting Stent Market Size & Forecast
    • 1.5.1 Global Coronary Drug-Eluting Stent Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Coronary Drug-Eluting Stent Sales Quantity (2021-2032)
    • 1.5.3 Global Coronary Drug-Eluting Stent Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Coronary Drug-Eluting Stent Product and Services
    • 2.1.4 Medtronic Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 Boston Scientific
    • 2.2.1 Boston Scientific Details
    • 2.2.2 Boston Scientific Major Business
    • 2.2.3 Boston Scientific Coronary Drug-Eluting Stent Product and Services
    • 2.2.4 Boston Scientific Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boston Scientific Recent Developments/Updates
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Coronary Drug-Eluting Stent Product and Services
    • 2.3.4 Abbott Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abbott Recent Developments/Updates
  • 2.4 B.Braun
    • 2.4.1 B.Braun Details
    • 2.4.2 B.Braun Major Business
    • 2.4.3 B.Braun Coronary Drug-Eluting Stent Product and Services
    • 2.4.4 B.Braun Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 B.Braun Recent Developments/Updates
  • 2.5 Biosensors International
    • 2.5.1 Biosensors International Details
    • 2.5.2 Biosensors International Major Business
    • 2.5.3 Biosensors International Coronary Drug-Eluting Stent Product and Services
    • 2.5.4 Biosensors International Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Biosensors International Recent Developments/Updates
  • 2.6 MicroPort
    • 2.6.1 MicroPort Details
    • 2.6.2 MicroPort Major Business
    • 2.6.3 MicroPort Coronary Drug-Eluting Stent Product and Services
    • 2.6.4 MicroPort Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 MicroPort Recent Developments/Updates
  • 2.7 Lepu Medical
    • 2.7.1 Lepu Medical Details
    • 2.7.2 Lepu Medical Major Business
    • 2.7.3 Lepu Medical Coronary Drug-Eluting Stent Product and Services
    • 2.7.4 Lepu Medical Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Lepu Medical Recent Developments/Updates
  • 2.8 Terumo
    • 2.8.1 Terumo Details
    • 2.8.2 Terumo Major Business
    • 2.8.3 Terumo Coronary Drug-Eluting Stent Product and Services
    • 2.8.4 Terumo Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Terumo Recent Developments/Updates
  • 2.9 Blue Sail Medical
    • 2.9.1 Blue Sail Medical Details
    • 2.9.2 Blue Sail Medical Major Business
    • 2.9.3 Blue Sail Medical Coronary Drug-Eluting Stent Product and Services
    • 2.9.4 Blue Sail Medical Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Blue Sail Medical Recent Developments/Updates
  • 2.10 SINOMED
    • 2.10.1 SINOMED Details
    • 2.10.2 SINOMED Major Business
    • 2.10.3 SINOMED Coronary Drug-Eluting Stent Product and Services
    • 2.10.4 SINOMED Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 SINOMED Recent Developments/Updates
  • 2.11 Liaoning Yinyi Biological
    • 2.11.1 Liaoning Yinyi Biological Details
    • 2.11.2 Liaoning Yinyi Biological Major Business
    • 2.11.3 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Product and Services
    • 2.11.4 Liaoning Yinyi Biological Coronary Drug-Eluting Stent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Liaoning Yinyi Biological Recent Developments/Updates

3 Competitive Environment: Coronary Drug-Eluting Stent by Manufacturer

  • 3.1 Global Coronary Drug-Eluting Stent Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Coronary Drug-Eluting Stent Revenue by Manufacturer (2021-2026)
  • 3.3 Global Coronary Drug-Eluting Stent Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Coronary Drug-Eluting Stent by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Coronary Drug-Eluting Stent Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Coronary Drug-Eluting Stent Manufacturer Market Share in 2025
  • 3.5 Coronary Drug-Eluting Stent Market: Overall Company Footprint Analysis
    • 3.5.1 Coronary Drug-Eluting Stent Market: Region Footprint
    • 3.5.2 Coronary Drug-Eluting Stent Market: Company Product Type Footprint
    • 3.5.3 Coronary Drug-Eluting Stent Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Coronary Drug-Eluting Stent Market Size by Region
    • 4.1.1 Global Coronary Drug-Eluting Stent Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Coronary Drug-Eluting Stent Consumption Value by Region (2021-2032)
    • 4.1.3 Global Coronary Drug-Eluting Stent Average Price by Region (2021-2032)
  • 4.2 North America Coronary Drug-Eluting Stent Consumption Value (2021-2032)
  • 4.3 Europe Coronary Drug-Eluting Stent Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Coronary Drug-Eluting Stent Consumption Value (2021-2032)
  • 4.5 South America Coronary Drug-Eluting Stent Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Coronary Drug-Eluting Stent Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Coronary Drug-Eluting Stent Sales Quantity by Type (2021-2032)
  • 5.2 Global Coronary Drug-Eluting Stent Consumption Value by Type (2021-2032)
  • 5.3 Global Coronary Drug-Eluting Stent Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Coronary Drug-Eluting Stent Sales Quantity by Application (2021-2032)
  • 6.2 Global Coronary Drug-Eluting Stent Consumption Value by Application (2021-2032)
  • 6.3 Global Coronary Drug-Eluting Stent Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Coronary Drug-Eluting Stent Sales Quantity by Type (2021-2032)
  • 7.2 North America Coronary Drug-Eluting Stent Sales Quantity by Application (2021-2032)
  • 7.3 North America Coronary Drug-Eluting Stent Market Size by Country
    • 7.3.1 North America Coronary Drug-Eluting Stent Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Coronary Drug-Eluting Stent Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Coronary Drug-Eluting Stent Sales Quantity by Type (2021-2032)
  • 8.2 Europe Coronary Drug-Eluting Stent Sales Quantity by Application (2021-2032)
  • 8.3 Europe Coronary Drug-Eluting Stent Market Size by Country
    • 8.3.1 Europe Coronary Drug-Eluting Stent Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Coronary Drug-Eluting Stent Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Coronary Drug-Eluting Stent Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Coronary Drug-Eluting Stent Market Size by Region
    • 9.3.1 Asia-Pacific Coronary Drug-Eluting Stent Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Coronary Drug-Eluting Stent Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Coronary Drug-Eluting Stent Sales Quantity by Type (2021-2032)
  • 10.2 South America Coronary Drug-Eluting Stent Sales Quantity by Application (2021-2032)
  • 10.3 South America Coronary Drug-Eluting Stent Market Size by Country
    • 10.3.1 South America Coronary Drug-Eluting Stent Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Coronary Drug-Eluting Stent Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Coronary Drug-Eluting Stent Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Coronary Drug-Eluting Stent Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Coronary Drug-Eluting Stent Market Size by Country
    • 11.3.1 Middle East & Africa Coronary Drug-Eluting Stent Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Coronary Drug-Eluting Stent Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Coronary Drug-Eluting Stent Market Drivers
  • 12.2 Coronary Drug-Eluting Stent Market Restraints
  • 12.3 Coronary Drug-Eluting Stent Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Coronary Drug-Eluting Stent and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Coronary Drug-Eluting Stent
  • 13.3 Coronary Drug-Eluting Stent Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Coronary Drug-Eluting Stent Typical Distributors
  • 14.3 Coronary Drug-Eluting Stent Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Coronary Drug-Eluting Stent market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Coronary Drug-Eluting Stent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Coronary Drug-Eluting Stent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Coronary Drug-Eluting Stent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Coronary Drug-Eluting Stent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Coronary Drug-Eluting Stent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Coronary Drug-Eluting Stent
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Coronary Drug-Eluting Stent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, B.Braun, Biosensors International, MicroPort, Lepu Medical, Terumo, Blue Sail Medical, SINOMED, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Coronary Drug-Eluting Stent market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Polymer Stent
    Polymer-Free Stent
    Others
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Medtronic
    Boston Scientific
    Abbott
    B.Braun
    Biosensors International
    MicroPort
    Lepu Medical
    Terumo
    Blue Sail Medical
    SINOMED
    Liaoning Yinyi Biological
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Coronary Drug-Eluting Stent product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Coronary Drug-Eluting Stent, with price, sales quantity, revenue, and global market share of Coronary Drug-Eluting Stent from 2021 to 2026.
    Chapter 3, the Coronary Drug-Eluting Stent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Coronary Drug-Eluting Stent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Coronary Drug-Eluting Stent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Coronary Drug-Eluting Stent.
    Chapter 14 and 15, to describe Coronary Drug-Eluting Stent sales channel, distributors, customers, research findings and conclusion.

    Buy now